| 82.78 Delayed Data As of Jun 14 |  +0.43 / +0.52%Today’s Change | 59.80 Today|||52-Week Range 84.27 | +8.34% Year-to-Date |
| Previous close | 82.35 |
| Today’s open | 82.71 |
| Day’s range | 82.46 - 83.37 |
| Volume | 7,623,999 |
| Average volume (3 months) | 10,107,697 |
| Market cap | $213.1B |
| Earnings growth (last year) | +165.32% |
| Earnings growth (this year) | +9.33% |
| Earnings growth (next 5 years) | +8.45% |
| Revenue growth (last year) | +6.17% |
| P/E ratio | 26.1 |
| Price/Sales | 4.82 |
| Price/Book | 8.04 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.07 | -0.08% |
| PFEPfizer | +0.26 | +0.61% |
| ABTAbbott Laboratories | -0.07 | -0.09% |
| ABBVAbbVie | -0.26 | -0.33% |
| Next reporting date | July 30, 2019 |
| EPS forecast (this quarter) | $1.15 |
| Annual revenue (last year) | $42.4B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 14.65% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer Kenneth C. Frazier |
CFO & Executive Vice President-Global Services Robert M. Davis |
Corporate headquarters Kenilworth, New Jersey |
